nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—CYP11B2—Mineralocorticoid biosynthesis—CGA—conduct disorder	0.183	0.19	CbGpPWpGaD
Etomidate—GABRB2—GABA A receptor activation—GABRA2—conduct disorder	0.0533	0.0555	CbGpPWpGaD
Etomidate—GABRG2—GABA A receptor activation—GABRA2—conduct disorder	0.0487	0.0507	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of steroid hormones and vitamin D—CGA—conduct disorder	0.0467	0.0487	CbGpPWpGaD
Etomidate—GABRA1—GABA A receptor activation—GABRA2—conduct disorder	0.0426	0.0444	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of steroid hormones and vitamin D—CGA—conduct disorder	0.0403	0.0419	CbGpPWpGaD
Etomidate—GABRB2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0326	0.034	CbGpPWpGaD
Etomidate—GABRG2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0298	0.0311	CbGpPWpGaD
Etomidate—CYP19A1—FSH signaling pathway—CGA—conduct disorder	0.0268	0.0279	CbGpPWpGaD
Etomidate—GABRA1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0261	0.0272	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of steroid hormones and vitamin D—CGA—conduct disorder	0.0228	0.0238	CbGpPWpGaD
Etomidate—Pseudoephedrine—MAOA—conduct disorder	0.0174	0.432	CrCbGaD
Etomidate—GABRB2—GABA receptor activation—GABRA2—conduct disorder	0.0173	0.018	CbGpPWpGaD
Etomidate—SLC2A1—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.0169	0.0176	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—SLC6A4—conduct disorder	0.0162	0.0169	CbGpPWpGaD
Etomidate—GABRG2—GABA receptor activation—GABRA2—conduct disorder	0.0158	0.0165	CbGpPWpGaD
Etomidate—GABRA1—GABA receptor activation—GABRA2—conduct disorder	0.0138	0.0144	CbGpPWpGaD
Etomidate—Pethidine—SLC6A4—conduct disorder	0.0116	0.289	CrCbGaD
Etomidate—ADRA2B—Monoamine GPCRs—DRD4—conduct disorder	0.0115	0.012	CbGpPWpGaD
Etomidate—Pseudoephedrine—SLC6A4—conduct disorder	0.0112	0.279	CrCbGaD
Etomidate—CYP11B2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0105	0.011	CbGpPWpGaD
Etomidate—GABRB2—Orphan transporters—GABRA2—conduct disorder	0.0101	0.0105	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00993	0.0103	CbGpPWpGaD
Etomidate—ADRA2B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0097	0.0101	CbGpPWpGaD
Etomidate—GABRG2—Orphan transporters—GABRA2—conduct disorder	0.00923	0.00962	CbGpPWpGaD
Etomidate—CYP11B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00907	0.00945	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—EP300—conduct disorder	0.0086	0.00896	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00817	0.00851	CbGpPWpGaD
Etomidate—GABRA1—Orphan transporters—GABRA2—conduct disorder	0.00807	0.0084	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00796	0.00829	CbGpPWpGaD
Etomidate—ADRA2B—Monoamine GPCRs—HTR2A—conduct disorder	0.00753	0.00784	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00728	0.00758	CbGpPWpGaD
Etomidate—GABRB2—Ion channel transport—GABRA2—conduct disorder	0.00708	0.00737	CbGpPWpGaD
Etomidate—GABRG2—Ion channel transport—GABRA2—conduct disorder	0.00647	0.00674	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00636	0.00663	CbGpPWpGaD
Etomidate—ADRA2B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00633	0.00659	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00598	0.00623	CbGpPWpGaD
Etomidate—GABRA1—Ion channel transport—GABRA2—conduct disorder	0.00566	0.0059	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—COMT—conduct disorder	0.00563	0.00586	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—MAOA—conduct disorder	0.00559	0.00582	CbGpPWpGaD
Etomidate—CYP11B2—Metapathway biotransformation—COMT—conduct disorder	0.00555	0.00578	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00547	0.0057	CbGpPWpGaD
Etomidate—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00514	0.00535	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—COMT—conduct disorder	0.00485	0.00505	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—MAOA—conduct disorder	0.00482	0.00502	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00479	0.00499	CbGpPWpGaD
Etomidate—CYP11B1—Metapathway biotransformation—COMT—conduct disorder	0.00478	0.00498	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00478	0.00498	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—GABRA2—conduct disorder	0.00458	0.00477	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—GABRA2—conduct disorder	0.00419	0.00437	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00413	0.0043	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CGA—conduct disorder	0.00408	0.00425	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0037	0.00386	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—GABRA2—conduct disorder	0.00366	0.00382	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00341	0.00355	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00288	0.003	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00286	0.00298	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00279	0.0029	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—COMT—conduct disorder	0.00275	0.00286	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—MAOA—conduct disorder	0.00273	0.00284	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—COMT—conduct disorder	0.00271	0.00282	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00263	0.00274	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00261	0.00272	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CGA—conduct disorder	0.00259	0.0027	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00246	0.00257	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.0024	0.0025	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00234	0.00244	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.0023	0.0024	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00228	0.00238	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00227	0.00237	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00225	0.00235	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00223	0.00232	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—COMT—conduct disorder	0.00221	0.0023	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—MAOA—conduct disorder	0.00219	0.00228	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CGA—conduct disorder	0.00213	0.00222	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—COMT—conduct disorder	0.00202	0.0021	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—MAOA—conduct disorder	0.002	0.00209	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00197	0.00205	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00191	0.00199	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—COMT—conduct disorder	0.00184	0.00192	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CGA—conduct disorder	0.00184	0.00191	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—MAOA—conduct disorder	0.00183	0.0019	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—COMT—conduct disorder	0.00176	0.00184	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—MAOA—conduct disorder	0.00175	0.00182	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.00147	0.00153	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00145	0.00151	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.00145	0.00151	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.00133	0.00139	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00131	0.00136	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00124	0.0013	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.0012	0.00125	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CGA—conduct disorder	0.00104	0.00109	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—COMT—conduct disorder	0.000963	0.001	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MAOA—conduct disorder	0.000956	0.000996	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.000948	0.000987	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EP300—conduct disorder	0.000943	0.000982	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000927	0.000966	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—COMT—conduct disorder	0.00083	0.000864	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MAOA—conduct disorder	0.000824	0.000858	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	0.000821	0.000855	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000799	0.000832	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—EP300—conduct disorder	0.000789	0.000822	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CGA—conduct disorder	0.000786	0.000819	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	0.000745	0.000777	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—WASF1—conduct disorder	0.00063	0.000656	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	0.000536	0.000558	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	0.000486	0.000507	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—COMT—conduct disorder	0.00047	0.00049	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MAOA—conduct disorder	0.000467	0.000486	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000453	0.000472	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—EP300—conduct disorder	0.000449	0.000468	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD4—conduct disorder	0.00044	0.000459	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—EP300—conduct disorder	0.000413	0.00043	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—EP300—conduct disorder	0.000356	0.000371	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	0.000287	0.000299	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—EP300—conduct disorder	0.000202	0.00021	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EP300—conduct disorder	0.000152	0.000159	CbGpPWpGaD
